Atika Capital Management LLC Alector, Inc. Transaction History
Atika Capital Management LLC
- $874 Million
- Q3 2024
A detailed history of Atika Capital Management LLC transactions in Alector, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 50,000 shares of ALEC stock, worth $103,000. This represents 0.23% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$103,000% of portfolio
0.23%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALEC
# of Institutions
167Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$18.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$11.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$9.54 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$8.97 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$5.62 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $170M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...